Skip to main navigation Skip to search Skip to main content

A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer

  • Byoung Chul Cho
  • , Melissa Johnson
  • , Jair Bar
  • , Eric Schaefer
  • , Kiyotaka Yoh
  • , Alona Zer
  • , Mor Moskovitz
  • , Se Hoon Lee
  • , Victor Moreno
  • , Maria de Miguel
  • , Yusuke Okuma
  • , Joo Hang Kim
  • , Chun Hui Lee
  • , Julio Peguero
  • , Peter Ansell
  • , Carla Biesdorf
  • , Rabih Saab
  • , Kevin J. Freise
  • , David Ramies
  • , Edwin E. Jeng
    • D. Ross Camidge
  • Yonsei University
  • Sarah Cannon Research Institute
  • Sheba Medical Center at Tel Hashomer
  • Highlands Oncology Group
  • National Cancer Center Japan
  • Technion-Israel Institute of Technology
  • Rabin Medical Center Israel
  • Fundacion Jimenez Diaz University Hospital
  • CEU Universities
  • CHA University
  • National Cheng Kung University
  • Oncology Consultants
  • AbbVie
  • University of Colorado Anschutz Medical Campus

Research output: Contribution to journal › Article › peer-review

7   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry